资源环境科技发展态势分析平台

13/12/2018

Pioneering researcher Professor Sir Gregory Winter was awarded the Nobel Prize in Chemistry on 10 December, the 16th laureate from the UK Research and Innovation’s Medical Research Council (MRC) Laboratory of Molecular Biology in Cambridge.

Sir Gregory, a former deputy director of the laboratory, was jointly awarded the prize with Frances Arnold and George Smith.

Sir Gregory and George Smith share half of the prize ‘for the phage display of peptides and antibodies’.

Professor Fiona Watt, Executive Chair of MRC, said when the award for Sir Gregory was announced in October: “Huge congratulations to Professor Sir Gregory Winter on this well-deserved accolade! 

"The pioneering breakthrough work by Sir Greg and his colleagues at the MRC Laboratory of Molecular Biology to develop humanised, and human, therapeutic antibodies has initiated a pharmaceutical revolution and led to the establishment of a whole new class of drugs which have helped millions of patients worldwide.  Today, monoclonal antibodies account for a third of all new treatments, such as the arthritis drugs adalimumab and Humira, the multiple sclerosis drug Lemtrada and the breast cancer drug Herceptin.

 “The MRC is proud to have funded Sir Greg Winter over many years to conduct this research. His success is a testament to the MRC’s strategy for long-term investment of taxpayers’ money in fundamental discovery research. This is the second Nobel celebration in two years at the MRC Laboratory of Molecular Biology – no wonder it’s known as the ‘Nobel prize factory’!”

Further information

• Professor Sir Gregory Winter awarded the Nobel Prize in Chemistry